Bausch Health Companies Inc.

Fundamentals6.0
Price Action6.0
News Sentiment0.0
AI Rating
6.0

Key Drivers

  • Margin Expansion
  • Debt Burden
  • Solid Liquidity

AI
AI Summary

6.0

BHC is increasingly a cash-flow turnaround story rather than just a distressed balance-sheet trade, but the real investment driver now is whether strong operating momentum and free cash flow can consistently reduce the $20.9B debt load fast enough to justify further upside, since any slowdown in execution or refinancing pressure could quickly cap the rerating.

Turnaround
Leverage
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Margin Expansion
  • Debt Burden
  • Solid Liquidity

BHC is showing improving quarterly profitability and strong free cash flow with high gross margins, but its investment case is still constrained by heavy debt, negative equity, and weak interest coverage.

CashFlow
Leverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher-high trend
  • $6 support hold
  • $7 breakout test

BHC has maintained a bullish short-term uptrend over the last month, but the move is volatile and needs to hold above $6.00 while reclaiming $7.00 to confirm continuation.

Bullish
Volatile
Support Level: $6.00 to $6.20
Resistance Level: $7.00

Sharp swings from late

Sentiment & News

0.0

Key News Insights:

  • Beat-and-raise
  • Debt burden
  • Board changes

Bausch Health delivered a beat-and-raise Q2 with broad revenue, earnings, and EBITDA outperformance that drove a sharp stock rally, but its heavy debt load remains the main risk.

Earnings
Debt

The operating beat and raised guidance are bullish for momentum, but leverage and interest expense continue to cap the investment case